Thyroid CancerNCT07823543
Educational Videos for Thyroid Surgery Patient
A study testing Thyroid Surgery Educational Video in people with Thyroid Cancer and Thyroid Nodule, run by West China Hospital.
Trial summary
The researchers aim to evaluate the performance of two groups of participants after receiving traditional education-one group supplemented with video-based education and the other without. Read more about this study
- Who is it for?
- Ages 18 to 60 yearsHealthy volunteers can take part
- Conditions the study is for
- Thyroid Cancer, Thyroid Nodule, TSH
- What is being tested?
- Thyroid Surgery Educational Video
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 400 participants
- Where
- No sites listed yet
- Study dates
- 1 Oct 2026to 1 Dec 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 60 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Patients scheduled for thyroid surgery, aged between 18 and 60 years old
Who cannot join
- Unable to read and write, pregnant, or with a history of thyroid surgery;
- suffering from other malignant tumors or mental disorders;
- unable to complete the questionnaire independently or requiring assistance from others.
About this study
Official title: Patient Education on Postoperative TSH Suppression Therapy for Differentiated Thyroid Cancer Using Science Popularization Videos: A Prospective, Multicenter, Randomized Controlled Trial
The researchers aim to evaluate the performance of two groups of participants after receiving traditional education-one group supplemented with video-based education and the other without. This study will explore the feasibility of using guideline-based public education videos on postoperative TSH suppression therapy for differentiated thyroid cancer in the context of public education regarding thyroid surgery.
- Conditions
- Thyroid Cancer, Thyroid Nodule, TSH, Education of Patients
- Being tested
- Thyroid Surgery Educational Video
- Medical subject headings
- Thyroid Neoplasms, Thyroid Nodule
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Thyroid Surgery Educational VideoOther
Accepting educational video on postoperative TSH suppression therapy for differentiated thyroid cancer created by researchers based on guidelines
| Study group | Role | What they receive |
|---|---|---|
| Intervention group | Experimental | Accepting educational video on postoperative TSH suppression therapy for differentiated thyroid cancer produced by researchers in accordance with guidelines Receives: Other: Thyroid Surgery Educational Video |
| Non-intervention group | No intervention | Without any additional intervention |
What is being measured
The primary outcome is the main question the study is designed to answer.
TSH Compliance Rate
The criteria for determining the TSH target achievement rate are based on a combination of three factors: the patient's postoperative recurrence risk stratification, the follow-up time point, and the current TSH test result. Within one year postoperatively, the TSH suppression targets are < 0.1 mU/L for the high-risk group, 0.1-0.5 mU/L for the moderate-risk group, and 0.1-0.5 mU/L (low Tg) or 0.5-2 mU/L (undetectable Tg, lobectomy) for the low-risk group. In statistical analysis, the TSH target range attainment rate = (number of patients with TSH levels within the target range at each follow-up time point / total number of patients followed up at that time point) × 100%
Measured: Postoperative Month 1, Postoperative Month 3, Postoperative Month 6, and Postoperative Month 12
Patient satisfaction
Patient satisfaction following different educational approaches was assessed using a 5-point Likert scale (1-5 scale; the higher the score, the higher the satisfaction).
Measured: Immediately after the educational presentation (post-intervention)
Secondary outcomes (4)
Level of knowledge dissemination
Knowledge assessment consists of 6 multiple-choice questions, 2 true/false questions, and 2 fill-in-the-blank questions to evaluate patients' understanding and awareness of educational topic.
Measured: Postoperative Month 1, Postoperative Month 3, Postoperative Month 6, and Postoperative Month 12
Patient anxiety level
Anxiety scale, thereby assessing the patient's level of anxiety. A 5-point Likert scale was used, with each item scored on a scale of 1 to 5, ranging from "not at all" to "very severe."
Measured: Baseline (before the educational outreach) and immediately after the educational outreach; two assessments total
Patient's Level of Regret After Surgery
Regret Scale, thereby recording the patient's degree of postoperative regret. 1. This was the right decision.
- I regret making this choice. 3. If I had the chance to do it over, I would make the same choice. 4. This choice caused me a lot of pain. 5. This was a wise decision. A 5-point Likert scale was used, with each item scored on a scale of 1 to 5; the lower the score, the less regret the respondent felt.
Measured: Baseline (before the educational outreach) and immediately after the educational outreach
Incidence of adverse events in patients
Whether the patient has forgotten to take medication or mistakenly recorded the follow-up appointment time, etc.
Measured: Postoperative Month 1, Postoperative Month 3, and Postoperative Month 6
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Sep 2026
- Study start1 Oct 2026 (estimated)
- Primary completion1 Dec 2027 (estimated)
- Study completion1 Dec 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Thyroid CancerStudies of the same condition, open and under way.
- More trials run by West China HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Single group
- Model description
- Accepting educational videos on thyroid health produced by researchers in accordance with guidelines
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 400 participants (estimated)
Sponsor and investigators
- Lead sponsor
- West China Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Jianyong Lei, West China Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07823543
- Sponsor's protocol ID
- 2026 Audit No. (1846)
- Status last verified
- Sep 2026
- First submitted
- 14 Dec 2025
- Last updated
- 16 Sep 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 16 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Patient Education on Postoperative TSH Suppression Therapy for Differentiated Thyroid Cancer Using Science Popularization Videos: A Prospective, Multicenter, Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT07823543
- Acronym / sponsor ID
- 2026 Audit No. (1846)
- Conditions
- Thyroid Cancer, Thyroid Nodule, TSH, Education of Patients
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 400 participants (estimated)
- Lead sponsor
- West China HospitalUniversity, hospital or other
- Study start
- 1 Oct 2026 (estimated)
- Primary completion
- 1 Dec 2027 (estimated)
- Study completion
- 1 Dec 2027 (estimated)
- First posted
- 16 Sep 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The researchers aim to evaluate the performance of two groups of participants after receiving traditional education-one group supplemented with video-based education and the other without. This study will explore the feasibility of using guideline-based public education videos on postoperative TSH suppression therapy for differentiated thyroid cancer in the context of public education regarding thyroid surgery.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
- Model description
- Accepting educational videos on thyroid health produced by researchers in accordance with guidelines
| Arm | Type | Receives |
|---|---|---|
| Intervention group | Experimental | Other: Thyroid Surgery Educational VideoAccepting educational video on postoperative TSH suppression therapy for differentiated thyroid cancer produced by researchers in accordance with guidelines |
| Non-intervention group | No intervention | –Without any additional intervention |
Who may qualify
- Ages
- 18 to 60 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (1 listed)
- Patients scheduled for thyroid surgery, aged between 18 and 60 years old
Key exclusion criteria (3 listed)
- Unable to read and write, pregnant, or with a history of thyroid surgery;
- suffering from other malignant tumors or mental disorders;
- unable to complete the questionnaire independently or requiring assistance from others.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Thyroid Surgery Educational VideoAccepting educational video on postoperative TSH suppression therapy for differentiated thyroid cancer created by researchers based on guidelines | Other | Intervention group |
Primary outcome
TSH Compliance Rate
Time frame: Postoperative Month 1, Postoperative Month 3, Postoperative Month 6, and Postoperative Month 12
The criteria for determining the TSH target achievement rate are based on a combination of three factors: the patient's postoperative recurrence risk stratification, the follow-up time point, and the current TSH test result. Within one year postoperatively, the TSH suppression targets are < 0.1 mU/L for the high-risk group, 0.1-0.5 mU/L for the moderate-risk group, and 0.1-0.5 mU/L (low Tg) or 0.5-2 mU/L (undetectable Tg, lobectomy) for the low-risk group. In statistical analysis, the TSH target range attainment rate = (number of patients with TSH levels within the target range at each follow-up time point / total number of patients followed up at that time point) × 100%
Patient satisfaction
Time frame: Immediately after the educational presentation (post-intervention)
Patient satisfaction following different educational approaches was assessed using a 5-point Likert scale (1-5 scale; the higher the score, the higher the satisfaction).
4 secondary outcomes
Level of knowledge dissemination
Time frame: Postoperative Month 1, Postoperative Month 3, Postoperative Month 6, and Postoperative Month 12
Patient anxiety level
Time frame: Baseline (before the educational outreach) and immediately after the educational outreach; two assessments total
Patient's Level of Regret After Surgery
Time frame: Baseline (before the educational outreach) and immediately after the educational outreach
Incidence of adverse events in patients
Time frame: Postoperative Month 1, Postoperative Month 3, and Postoperative Month 6
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Sep 2026.
Related trials for Thyroid Cancer
Not yet recruitingPhase 1/2
177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer
Thyroid Cancer
RecruitingObservational study
Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms
Endocrine Tumors, Thyroid Neoplasms
RecruitingObservational study
Studies on Tumors of the Thyroid
Hurthle Cell Thyroid Cancer, Tall Cell Variant Thyroid Cancer
RecruitingPhase 2
The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer
Metastic Thyroid Cancer
RecruitingObservational study
International PPB/DICER1 Registry
Pleuropulmonary Blastoma, Sertoli-Leydig Cell Tumor
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
A study testing Thyroid Surgery Educational Video in people with Thyroid Cancer and Thyroid Nodule, run by West China Hospital.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 16 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
TSH Compliance Rate (time frame: Postoperative Month 1, Postoperative Month 3, Postoperative Month 6, and Postoperative Month 12). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Sep 2026.